Subscribe

Lynne Lederman, PhD

Articles by Lynne Lederman, PhD

Later-Generation Cell Therapies Increase Utility in Hematologic Malignancies

ByLynne Lederman, PhD

August 22nd 2021

CAR T-cell therapy use will likely expand to a wider array of hematologic malignancies.

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial

© 2025 MJH Life Sciences^®

All rights reserved.